FFCP PHASE2:Hg19::chr12:123011821..123011835,+
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p2@KNTC1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_2_at_KNTC1_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 12bp_to_NM_014708, uc001ucv.2, uc010taf.1_5end |
EntrezGene: | KNTC1 |
HGNC: | 17255 |
UniProt: | P50748 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p2@KNTC1 |
---|
0.0
2.5
5.0
7.5
10.0
12.5
15.0
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 1.95e-43 | 235 |
disease of cellular proliferation | 5.40e-43 | 239 |
cell type cancer | 4.70e-22 | 143 |
carcinoma | 4.63e-20 | 106 |
organ system cancer | 6.87e-20 | 137 |
hematologic cancer | 1.09e-19 | 51 |
immune system cancer | 1.09e-19 | 51 |
leukemia | 1.60e-15 | 39 |
myeloid leukemia | 1.62e-11 | 31 |
Showing 1 to 9 of 9 entries